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Receptor specificity is a critical determinant of viral tropism, but the capacity of viruses to switch to alternative receptors has not been
extensively studied. Here, we engineered the attachment protein of an attenuated measles virus and generated truly retargeted viruses that are
blind to the native receptors CD46 and SLAM, but which propagate efficiently and exclusively via alternative cellular receptors, epidermal
growth factor receptor, or CD38. The engineered receptor tropisms were stably maintained during multiple serial virus passage without
reversion to native receptor usage, even on cells offering the choice of both native and alternative receptors. We conclude that
paramyxoviruses have a remarkably flexible and adaptable entry mechanism.
D 2004 Elsevier Inc. All rights reserved.
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Receptor recognition leading to virus entry is the first
critical step in the viral life cycle and is therefore implicated
in the evolution of new tissue or species tropisms
(Baranowski et al., 2003). The family Paramyxoviridae
harbors a broad spectrum of serious pathogens (Lamb and
Kolakofsky, 2001) and continues to evolve (Jensen et al.,
2002) (Field et al., 2001). In contrast to other virus families,
paramyxoviral attachment and fusion triggering functions
are provided on separate proteins (Lamb, 1993), an arrange-
ment that may uniquely facilitate the modification of
receptor recognition without compromising fusion trigger-
ing. Various polypeptide ligands have been displayed on
measles viruses as C-terminal extensions of the viral
attachment protein H (Bucheit et al., 2003; Hammond et
al., 2001; Peng et al., 2003, 2004). However, until now it
was undetermined whether measles viruses could be
engineered to propagate exclusively via alternative cellular0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.08.036
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E-mail address: sjr@mayo.edu (S.J. Russell).receptors. Here, by restructuring their attachment proteins,
we have fully retargeted the receptor tropisms of replication-
competent attenuated measles viruses, thereby demonstrat-
ing the remarkable flexibility of the paramyxovirus entry
mechanism.Results
Residues in the measles virus attachment protein (H)
interacting with the mature viral receptors, CD46 and
SLAM, have been previously characterized (Bartz et al.,
1996; Nielsen et al., 2001; Vongpunsawad et al., 2004).
Alanine substitutions at residues 481 and 533 eliminated
(respectively) CD46 and SLAM receptor-specific fusion
support functions of chimeric H proteins displaying scFvs at
their C-termini but did not interfere with scFv-directed
fusion support (Nakamura et al., 2004). To generate
retargeted measles viruses, we constructed genes coding
for doubly ablated (481A, 533A) chimeric H proteins fused
to C-terminal scFvs against human EGFR or human CD38
(Nakamura et al., 2004) and cloned them into a full-length
measles virus genome containing an additional transcription
unit coding for GFP (Fig. 1A). The retargeted viruses and04) 217–225
Rapid Communication218the nontargeted control virus were rescued using a modified
rescue system (Radecke et al., 1995) overlaid with Vero cell
transfectants stably expressing human CD38 (Fig. 1B). For
each of the viral genomic plasmids, rescued viruses were
identifiable as rapidly enlarging green fluorescence syncytia
and were subsequently amplified and titrated on Vero CD38
cells, which express receptors for all three viruses (CD46,
EGFR, and CD38) and therefore serve as a universal
substrate. One-step growth curves show that virus growth
kinetics and maximum virus yields were remarkably similar
for all three viruses on Vero-CD38 cells (Fig. 1C). The
relative particle to infectivity ratios of retargeted and control
virus stocks were estimated by immunoblotting for the most
abundant viral structural protein N. From the bandintensities (Fig. 1D), it can be concluded that the N-protein
content does not differ significantly between virus prepara-
tions, suggesting approximate equivalence of particle to
infectivity ratios for all three viruses on Vero-CD38 cells. In
contrast to the similar intensities of N-protein staining, the
intensity of the H-protein band in anti-H immunoblots was
approximately 10-fold less intense in scFv-displaying virus
stocks compared to those with unmodified H-proteins,
indicating that the chimeric H proteins may be less
efficiently incorporated into virus particles. This may be a
consequence of impaired folding and transport due to the
more complex structure of the chimeric proteins. However,
the infectivity of the scFv displaying viral stocks is well-
maintained, suggesting that unmodified measles viruses
contain a considerable excess of H-protein relative to their
requirements, and that H abundance is not limiting for virus
entry. This interpretation assumes that the relative abun-
dance of H and N proteins in these virus stocks provide a
true reflection of the composition of the infectious virions.
We next evaluated the specificity of receptor usage of
recombinant viruses by testing their infectivity on stably
transfected Chinese hamster ovary (CHO) cells expressing
each of the receptors of interest (Fig. 2A). As shown in Fig.
2B, CHO cells expressing either of the natural measles virus
receptors, CD46 or SLAM, were infected exclusively by
viruses with unmodified H-proteins, whereas EGFR-pos-
itive CHO cells were infected efficiently and exclusively by
EGFR-targeted virus, and CD38-positive CHO cells were
infected exclusively by the CD38-targeted virus. Thus, MV-
Edm is capable of efficient, targeted cell entry when tethered
to the cell surface via an ectopic binding domain appended
to the extreme C-terminus of a receptor-blind H-protein.
These observations provide a novel insight into the
mechanism by which interaction between H and its receptor
triggers the conformational rearrangement of the F protein
that catalyses fusion between the measles virus envelope
and its target cell membranes. Contrary to existing models
(Lamb, 1993; Morrison, 2003), our data suggest that the
fusion mechanism is unlikely to involve receptor-triggeredFig. 1. Construction, propagation, and biochemical characterization of
recombinant viruses. (A) Recombinant measles virus genome schematic
showing additional transcription unit for green fluorescent protein (GFP)
and engineered H-protein modifications including an N-terminal FLAG tag,
mutations of the CD46 interacting residue Y481A and the SLAM
interacting residue R533A, and a C-terminal scFv (either anti-CD38 or
anti-EGFR) adjacent to an inserted factor Xa cleavage site (IEGR) and
flanked by Sfi1/Not1 restriction sites. (B) FACS profiles of Vero-38 cells
stained with antibodies to CD38-FITC, EGFR-FITC (bold lines), or isotype
control (solid line). (C) One-step growth curves of recombinant viruses in
Vero-38 cells. Cells were infected at a multiplicity of 3.0 TCID50/cell and
cell-associated virus was harvested and titrated at intervals following
infection. (D) Protein composition of recombinant viruses. Viruses were
titrated on Vero-38 cells and equal titers (TCID50) were resolved by SDS-
PAGE, transferred to Immunoblot PVDF membrane (Bio-Rad), and probed
with anti-measles antibodies. The left panel was probed with primary rabbit
anti-H followed by HRP-labeled goat anti-rabbit. The right panel was
probed with monoclonal mouse anti-N antibody followed by HRP-labeled
goat anti-mouse.
Fig. 2. Receptor specificity of recombinant viruses. (A) FACS scan analysis of CHO cell transfectants stably expressing the relevant receptors; isotype control
(solid black line); anti-receptor antibodies (colored lines: aCD46 blue, aCD38 red, aEGFR green, aSLAM orange). (B) Targeted virus entry. CHO cells were
infected with the recombinant viruses (MOI = 1.0) and were photographed 48 h later under blue light to show green fluorescence syncytia. Scale bar = 300 Am.
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Rapid Communication220conformational change in the H-protein but is more likely
due to immobilization of the receptor-tethered H-protein,
leading to its association or dissociation from F, thereby
unmasking the fusogenic activity of the F protein.
After showing specificity of the retargeted viruses on
CHO cell transfectants expressing very high levels of
individual receptors, we next studied their specificity on
human cell lines expressing the relevant receptors in various
combinations and at varying levels, not artificially deter-
mined by plasmid transfection (Fig. 3A). Viral infection of
each of the indicator cells was monitored by scoring theFig. 3. Targeted infection of human tumor cell lines. (A) FACS scan analysis of r
(colored lines: aCD46 blue, aCD38 red, aEGFR green, aSLAM orange). (B)
Fluorescence microscopy of infected cells in the presence of fusion inhibitory pep
virally infected cells can be determined by flow cytometric analysis of FIP-treated
on receptor-positive and -negative human tumor cell lines. The cells were infect
(BxPC-3 and SKOV3ip.1). In the presence of FIP, green fluorescent cells were coun
those of the parental MV-GFP virus (100%).syncytial viral cytopathic effect (Fig. 3B) or by inhibiting
syncytium formation and preventing further rounds of
infection using a fusion inhibitor peptide (FIP) and counting
individual GFP fluorescent-infected cells by FACS (Fig.
3C). The conclusion of these studies, illustrated on a
representative cell panel in Fig. 3, is that the host-range
properties of the retargeted measles viruses are determined
entirely by the displayed antibodies. While CD46 and
SLAM are the best characterized measles virus receptors
(Dorig et al., 1993; Tatsuo and Yanagi, 2002), evidence has
been presented in support of a third receptor present onelevant receptors; isotype control (solid black line); anti-receptor antibodies
Phase contrast and fluorescent microscopy of infected tumor cell lines.
tide (FIP) is included in the K562 panel to illustrate that the percentage of
infectants, shown in panel C. (C) Relative infectivities of engineered viruses
ed with recombinant viruses at MOI = 1 (K562 and Jurkat) or MOI = 0.1
ted by FACS scan after 48 h and transduction efficiencies were compared to
Rapid Communication 221human cells (Andres et al., 2003; Hashimoto et al., 2002).
Since our retargeted viruses showed greatly reduced
infectivity on cells lacking the retargeted receptors, weFig. 4. Stability of retargeted viruses during multiple serial passage. (A) Protein c
after 3rd and 11th serial passage on Vero-38 cells. These virus stocks were titered
and resolved on SDS-PAGE for immunoblotting. The blot was probed with ra
visualization by chemiluminescence. The membrane was stripped and reprobed w
mouse (right panel). (B) Host-range properties of retargeted viruses after 10 ser
infected with the indicated viruses at MOI = 1, and the cells were photographed 4
engineered viruses at passages 3 and 10 on receptor-positive and -negative human t
(Jurkat) or MOI = 0.1 (SKOV3ip.1). In the presence of FIP, green fluorescent cells
case to the positive passage 3 virus (100%).conclude that the combination of 481A and 533A mutations,
with a displayed scFv, effectively hinders interaction with
the putative third receptor.omposition of serially passaged virus. Recombinant viruses were harvested
on Vero-38 and equal amounts (150000 TCID50) were loaded in each well
bbit anti-H antibody followed by HRP goat anti-rabbit (left panel) after
ith murine monoclonal anti-N antibody followed by HRP-labeled goat anti-
ial passages on Vero-38 cells. Receptor-positive and -negative cells were
8 h after infection under blue ultraviolet light. (C) Relative infectivities of
umor cell lines. The cells were infected with recombinant viruses at MOI = 1
were counted after 48 h and transduction efficiencies were compared in each
Rapid Communication222Like other RNA viruses, measles virus has a high
mutation rate, estimated at 9  105 per base per
replication giving a genomic mutation rate of 1.43 per
replication (Schrag et al., 1999). Therefore, a stock of
measles viruses derived from a single infectious unit is not
clonal, but consists of a diverse population of genetic
microvariants known as quasispecies. It is therefore
expected that a stock of bretargetedQ measles viruses may
contain occasional revertants capable of using the original
virus receptors, CD46 or SLAM. To determine whether
receptor revertants have a selective advantage, we sub-
jected the retargeted viruses to serial passage on Vero-
CD38 cells that express abundant native measles virus
receptors (CD46) as well as the retargeted receptors, CD38
and EGFR. Even after multiple serial passages on Vero
CD38 cells, the host-range properties of the retargeted
viruses did not change (Figs. 4B and C). They did not lose
the ability to utilize their targeted receptors, nor did they
reacquire the ability to enter cells through CD46. In
keeping with these observations, the H-proteins detected
on immunoblots of the retargeted viruses harvested after 11
serial passages on Vero CD38 cells remained entirely
chimeric (Fig. 4A).Discussion
The data presented in this manuscript provide a first
demonstration that measles virus can be fully retargeted by
engineering its attachment protein H. Specific mutations in
the H coding sequence ablated the natural tropisms for
CD46 and SLAM, whereas new receptor specificities were
introduced by fusing single chain antibodies to the C-
terminus of the ablated H proteins. The retargeted viruses
were able to propagate efficiently and exclusively via their
targeted receptors, and revertants with natural tropisms did
not emerge even after serial passage on cells that offered the
choice of both natural and targeted receptors.
The cellular receptors for the retargeted viruses that
were generated for this study belong to widely differing
receptor families. CD38 is a 45-kDa type II transmembrane
glycoprotein with NADP glycohydrolase and cell signaling
activity (Mehta et al., 1996), whereas EGFR is a type I
membrane glycoprotein that undergoes dimerization and
rapid endocytosis upon binding EGF (Carpenter, 1992). In
contrast, the natural viral receptors CD46 and SLAM are
type I membrane glycoproteins belonging, respectively, to
the regulators of complement activation (RCA) (Lublin et
al., 1988) and to the immunoglobulin superfamily (Cocks
et al., 1995). Thus, although we have not exhaustively
tested the full spectrum of receptors available on the
surface of mammalian cells, our data show that receptor
choice is not a major limiting factor for measles virus
entry. Indeed, we previously reported that nonablated
measles viruses, displaying additional scFvs or single-
chain T cell receptors, can enter rodent cells usingcarcinoembryonic antigen (Hammond et al., 2001), CD38
(Peng et al., 2003), or specific MHC peptide complexes
(Peng et al., 2004) as receptors. However, by expressing
hybrid receptors composed of varying numbers of the short
consensus repeat domains of CD46 (which mediate virus
attachment) anchored to a variable number of Ig-like
domains from another cellular protein (Buchholz et al.,
1996), it was previously determined that fusion triggering
and virus entry are poorly supported by very long or very
short receptors. It is therefore expected that certain cellular
receptors will not provide a suitable portal for measles
virus entry.
In contrast to the family Paramyxoviridae, the attach-
ment and fusion triggering functions of many enveloped
viruses are combined in a single envelope glycoprotein
(Eckert and Kim, 2001), an arrangement that appears to be
considerably more constraining for receptor choice. Numer-
ous attempts to manipulate retrovirus entry by incorporating
cell binding ligands into the envelope glycoprotein have led
to efficient retargeted attachment, but a very low efficiency
of cell entry through the targeted receptor (Lavillette et al.,
2001). Compared to other virus families, the family
Paramyxoviridae contains an extraordinary spectrum of
human and veterinary pathogens (Lamb and Kolakofsky,
2001). The separation of attachment and fusion functions
onto separate envelope glycoproteins apparently confers the
Paramyxoviridae with a high degree of flexibility with
respect to receptor usage. Not only does this insight help
explain their success as established pathogens and their
continuing relevance as emerging pathogens, but it also
suggests that Paramyxoviridae may be ideal targetable
oncolytic agents.Materials and methods
Cell culture
CHO cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% FBS. CHO-
CD46, CHO-CD38, and CHO-EGFR were grown in
DMEM with 10% FBS containing 1 mg/ml G418. CHO-
SLAM were grown in RPMI 1640 with 10% FBS
containing 0.5 mg/ml G418. Jurkat T-cell leukemia cells,
K562 human erythroleukemic cells, and BxPC-3 human
pancreatic cancer were grown in RPMI 1640 with 10%
FBS, Vero African green monkey kidney cells were grown
in DMEM with 10% FBS, and all were purchased from
American Type Culture Collection (ATCC, Manassas, VA).
These cells were grown in media as recommended by the
supplier. The SKOV3ip.1 ovarian tumor cells were main-
tained in alpha-MEM (Irvine Scientific, Santa Ana, CA)
supplemented with 20% FBS. Vero-38 cells were main-
tained in DMEM supplemented with 5% FBS containing 0.5
mg/ml G418. All cells were maintained at 37 8C in an
atmosphere of 5% CO2.
L negative log10 of the most concentrated virus dilution tested in
which all wells are positive
d log10 of dilution factor
s sum of individual proportions pi
pi calculated proportion of an individual dilution
v volume of inoculum (ml/well)
Rapid Communication 223Receptor detection by flow cytometry
Cells were harvested and washed twice with cold PBS
containing 2% BSA. Cells were then incubated with either
anti-CD46-FITC, anti-CD38-FITC, anti-IgG1-FITC, anti-
CD150-PE (PharMingen, San Diego, CA), or anti-EGFR-
FITC (Santa Cruz Biotechnology, Inc. Santa Cruz, CA) for
1 h on ice. At completion of the incubation, the cells were
washed with 2% BSA in PBS and then fixed in 4%
paraformaldehyde for 10 min on ice. The cells were
washed again and resuspended in 2% BSA in PBS and
analyzed on a Becton-Dickinson FACScan Plus cytometer
and analyzed using the Cell Quest software (Becton-
Dickson, San Jose, CA).
Generation of Vero-38 rescue cells
Vero-38 cells were generated by transfecting Vero cells
with CD38 expressing plasmid (Peng et al., 2003) using the
calcium phosphate method and selecting for clones that
stably express the CD38 antigen using 1 mg/ml G418.
Clones that expressed high levels of CD38 were identified
by flow cytometry using a FITC-conjugated anti-CD38
antibody (Caltech, Burlingame, CA).
Construction of p(+)MV-HAAaCD38 and
p(+)MV-HAAaEGFR plasmids
All H glycoproteins contain a FLAG tag inserted after the
start codon (Peng et al., 2003) to facilitate detection of
virions. The cDNA encoding the scFv for aCD38 was
digested as a Sfi1/Not1 fragment from pCGHX-aCD38
(Peng et al., 2003) and subcloned into the Sfi1/Not1-
digested pCGHAAXaEGFR plasmid (Nakamura et al.,
2004). The cDNA encoding the scFv for aEGFR was
corrected to comply with the rule of six using primers
SfiEGFRscFv (5V GTCC ATGC GGCC CAGC CGGC
CATG GCCC AGGT GCAG CTGC) and EGFRscFvNot
(5VTTTT CCTT TTGC GGCC GCTT TCAT CATC AGTT
GATC TCGA GTTC TGTC C) on the scFv template. The
Sfi1/Not1-digested PCR fragment was subcloned into the
Sfi1/Not1-digested pCGHAAXaEGFR plasmid (Nakamura
et al., 2004). To allow easy cloning of the chimeric H
cDNAs into plasmid p(+) MV-eGFP that encodes the full-
length infectious clone of MV-NSe and a green fluorescent
protein (GFP) as an additional transcription unit upstream of
N, the extra Spe1 site in p(+) MV-eGFP was removed by
replacing the SacII/Spe1 fragment with MV-NSe to generate
p(+) MV-eGFP (Spe). The chimeric H fragments were
digested using Pac1/Spe1 enzymes and subcloned into p(+)
MV-eGFP (Spe).
Virus rescue
Viruses were rescued using a well-established rescue
system (Radecke et al., 1995) in combination withCD38-transfected Vero cells. Briefly, producer 293-3-46
cells were transfected with p(+)MV-eGFP-HAAaCD38 or
p(+)MV-eGFP-HAAaEGFR (5 Ag) and pEMCLA (50 ng)
using ProFection Mammalian Transfection System Cal-
cium Phospate kit from Promega (Madison, WI). Forty-
eight hours after transfection, the 293-3-46 cells were
lifted with versene and overlaid onto Vero-38 cells.
When individual green syncytia formed in the overlays,
they were harvested and used to infect new Vero-38
cells.
Virus preparation
Vero or Vero-38 cells were plated in T-75 flasks at a
density of 1.5  106 cells per flask and infected the next day
at a MOI = 0.02 in Opti-MEM (Invitrogen, Carlsbad, CA).
The infection was continued for 4 h at 37 8C, at which point
the virus solution was removed, growth medium was
replaced, and cells were returned to 37 8C. The cells were
watched until they were N80% in syncytia. At this point, the
medium was carefully aspirated and 2 ml per flask Opti-
MEM was added. Cells were scraped into this solution and
subjected to three rounds of freeze–thawing. The cell debris
was pelleted by centrifugation and the cleared cell lysate
was then aliquoted and tittered. Virus aliquots were stored at
80 8C.
Determination of virus titers
Vero or Vero-38 cells were plated overnight at a density
of 7000 cells per well in 96-well plates. Viral cell lysates
were diluted serially in Opti-MEM from a dilution of 1:101
to 1:1010. Each virus dilution was added to eight wells of
cells as replicates in 50 Al/well. Titer plates were incubated
at 37 8C for 6 days. At the completion of the incubation,
titer plates were read and each well was scored as + or 
syncytia. The TCID50 values were determined by the
Spearman and K7rber equation: Log10 (TCID50/ml) = L +
d(s  0.5) + log10(1/v)Serial passage of virus
Vero-38 cells were infected at a low MOI with both of
the retargeted viruses in Opti-MEM at 37 8C for 4 h. After
infection, growth media were replaced. They were kept at
37 8C until large green syncytia formed; when the cells were
N70% in syncytia, the virus was harvested and used to infect
new Vero-38 cells. This process was continued over 11
passages for each virus.
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Virus samples were incubated with lysis buffer (20 mM
Tris–HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.05%
SDS, 0.5% sodium deoxycholate, 1 mM PMSF) and sample
buffer at room temperature for 15 min prior to loading on a
7.5% Criterion gel (Bio-Rad, Hercules, CA). Following
SDS-PAGE, the gel was transferred to Immunoblot PVDF
membrane in a Trans-blot electrophoretic transfer cell (Bio-
Rad) at 15 V for 45 min. The PVDF membrane was
blocked with 5% nonfat dry milk (NFDM) in TBS-T (10
mM Tris base, 100 mM NaCl, pH 7.5 with 0.1% Tween 20)
for 18 h at 4 8C. Primary antibody incubations were carried
out in 2.5% NFDM in TBS-T for 24 h at 4 8C. Anti-N
antibody was mouse monoclonal to measles nucleoprotein
Clone 3E1 at 1:3000 dilution (Novus Biologicals, Littleton,
CO) and Anti-H polyclonal antibody at 1:10000 dilution
(gift from Dr. Roberto Cattaneo, Mayo Clinic, Rochester,
MN). At the completion of the primary incubation, the blots
were washed three times in TBS-T for 15 min each. The
secondary antibody was applied for 2 h at room temper-
ature, for the anti-N blot we used goat anti mouse-HRP
(KPL, Galthersburg, MD) at 1:10000 and for the anti-H
blot goat anti-rabbit-HRP (Calbiochem, San Diego, CA) at
1:3000. Then the blots were washed in TBS-T as above and
visualized with the SuperSignal West Pico Chemilumines-
cent Substrate (Pierce Chemical, St. Louis, MO) according
to the manufacturer’s instructions.
Characterization of infectivity by flow cytometry
Cells were plated 24 h prior to infection to yield a density
of near 50–60% confluence at the time of infection.
Immediately before infection, media were removed from
cells and replaced with Opti-MEM. Virus was applied to
each well to yield the appropriate multiplicity of infection
(MOI). Infection was allowed to continue for 2 h at 37 8C, at
the completion of the infection time the virus solution was
replaced with growth media plus FIP (fusion inhibitory
peptide; Bachem, Torrance, CA) at a final concentration of
40 Ag/ml. Cells were studied 48 h post-infection. Media
were aspirated and cells were washed with PBS. Cells were
lifted with trypsin and neutralized with tissue culture media.
Cells were washed once with 2% BSA in PBS then fixed
with 4% paraformaldehyde for 10 min on ice. Finally, cells
were washed, resuspended with 2% BSA in PBS, and
analyzed by FACS.Acknowledgments
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